It works by targeting the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, promoting reduced appetite, improved glycemic management, and weight loss
[1] [2] This medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptyingan effect that is most pronounced after initial doses and may attenuate over timeleading to reduced appetite and caloric intake
Quines pueden utilizar tirzepatida La indicacin principal de tirzepatida corresponde a adultos con obesidad (IMC 30) o sobrepeso (IMC 27) que presentan alguna condicin asociada: hipertensin arterial, colesterol alto, insuficiencia cardaca, prediabetes o apnea del sueo
It's worth noting that tirzepatide's effect on slowing gastric emptying may affect the absorption of oral medications taken concurrently
Promotion of neurogenesis and synaptic plasticity : Animal studies suggest GLP-1 agonists may stimulate the growth of new neurons and strengthen synaptic connections, particularly in the hippocampus